Logo
  • Investing
  • Stock
  • Economy
  • Latest News
Skip to content
Investing
  • Economy
  • Investing
  • Latest News
  • Stock
#
Categories Investing

Fortune Bay

November 4, 2025

#
Categories Investing

Locksley Resources LimitedReceives up to US$191M Potential Support from EXIM Bank

November 3, 2025

Perth, Australia (ABN Newswire) – Locksley Resources Limited (ASX:LKY,OTC:LKYRF) (FRA:X5L) (OTCMKTS:LKYRF) announced the receipt of a Letter of Interest (‘LOI’) from

#
Categories Investing

Corcel Exploration: Advancing a District-scale, Past-producing Copper-Gold Asset in Arizona

November 3, 2025

Corcel Exploration (CSE:CRCL,OTCQB:CRLEF) is a Vancouver-based explorer unlocking copper and gold opportunities across North America. Anchored by its flagship Yuma King project

#
Categories Investing

Sarama Files Memorial in US$242M Damages Claim Against Burkina Faso

November 3, 2025

Sarama Resources Ltd. (“Sarama” or the “Company”) (TSX-V:SWA, ASX:SRR) announces that it has filed its written Memorial (the “Memorial”) detailing the Company’s

#
Categories Investing

Investor Webinar, Wednesday 5th Nov, 11:30am AEDT

November 3, 2025

Locksley Resources Limited (ASX: LKY, OTCQX: LKYRF, FSE: X5L) (“Locksley” or the “Company”), advises that the Company will host an investor webinar

#
Categories Investing

CleanTech Lithium

November 3, 2025

#
Categories Investing

CHARBONE Engage la Societe Americaine de Relations aux Investisseurs RBMG

November 1, 2025

(TheNewswire) Brossard, Quebec TheNewswire

#
Categories Investing

LaFleur Minerals Inc.Emerging Among Peers as Attractive, Resilient Investment Play

November 1, 2025

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. Via InvestorWire — LaFleur

#
Categories Investing

JZR Gold Announces Full Exercise of Warrants for Proceeds of $1.6 Million

November 1, 2025

(TheNewswire) NOT

#
Categories Investing

CHARBONE Engages US-Based Investor Relations Firm RBMG

November 1, 2025

(TheNewswire) Brossard, Quebec TheNewswire

Posts navigation

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!



    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Trending News

    • Recent Posts
    #

    Top catalysts for the Dow Jones Index and the DIA ETF in December

    The Dow Jones continued its strong rally in December, hitting its all-time on record. It has now...

    #

    Nio stock price analysis: will this crash accelerate or end soon?

    Nio stock price has plunged in the past four consecutive weeks as investors reacted to its recent...

    #

    Salesforce stock price forms a risky pattern ahead of earnings

    Salesforce stock price remained under intense pressure in November as concerns about the...

    #

    A beginner’s guide to the yen carry trade: why it’s so profitable, and so dangerous

    Borrow cheap yen, invest in higher-yielding assets, pocket the spread: repeat with leverage.That...

    #

    Crypto crash: Will Bitcoin and altcoins recover in December?

    A crypto crash is happening this month, erasing billions of dollars in market capitalization from...

    #

    Rolls-Royce share price forecast for December: will it rebound?

    Rolls-Royce share price remains under pressure this month, moving from the year-to-date high of...

    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: Biotech-savvy.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 Biotech-savvy.com